The latest closing stock price for Kyverna Therapeutics as of February 21, 2025 is 2.78.
An investor who bought $1,000 worth of Kyverna Therapeutics stock at the IPO in 2024 would have $-907 today, roughly -1 times their original investment - a -90.73% compound annual growth rate over 1 years.
The all-time high Kyverna Therapeutics stock closing price was 30.10 on February 09, 2024.
The Kyverna Therapeutics 52-week high stock price is 30.60, which is 1000.7% above the current share price.
The Kyverna Therapeutics 52-week low stock price is 2.65, which is 4.7% below the current share price.
The average Kyverna Therapeutics stock price for the last 52 weeks is 10.17.
An investor who bought $1,000 worth of Kyverna Therapeutics stock at the IPO in 2024 would have $-907 today, roughly -1 times their original investment - a -90.73% compound annual growth rate over 1 years.
The all-time high Kyverna Therapeutics stock closing price was 30.10 on February 09, 2024.
The Kyverna Therapeutics 52-week high stock price is 30.60, which is 1000.7% above the current share price.
The Kyverna Therapeutics 52-week low stock price is 2.65, which is 4.7% below the current share price.
The average Kyverna Therapeutics stock price for the last 52 weeks is 10.17.